ArticleClinical genitourinary cancer2026

Outcomes for Patients With SPOP Mutated Castration-Resistant Prostate Cancer (CRPC) Treated With an Androgen Receptor Pathway Inhibitor (ARPI).

Joseph J Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.